Aardvark Therapeutics Announces Inducement Grant

Aardvark Therapeutics announced an inducement grant under Nasdaq Listing Rule 5635(c)(4). The company is a clinical-stage biopharmaceutical firm focused on developing small-molecule therapeutics for metabolic diseases.